Thursday, June 12, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2024 February

Monthly Archives: February 2024

2024 Watch List

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

Editor / Curator -
All News

Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut...

Editor / Curator -
2024 Watch List

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX)...

Editor / Curator -
2024 Watch List

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic...

Editor / Curator -
2024 Watch List

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

Editor / Curator -
All News

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million...

Editor / Curator -
All News

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Editor / Curator -
2024 Watch List

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Editor / Curator -
2024 Watch List

GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

Editor / Curator -
12Page 1 of 2

Latest article

Who’s the Next Eric Sprott?

Uncategorized Editor / Curator -
To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...

Perpetua (PPTA) Raises $300 Million.

All News Editor / Curator -
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...

Brixton Metals (BBBXF) $0.072, Leaps 62%. On No News.

All News Editor / Curator -
Institutional Gold Analyst It's always fun to decide on a single word, to describe a 62% single day price gain. Should we use "rose, surged,...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.